Research Article
Assessment of Patients’ Future Outlook after Bowel Resection in Crohn’s Disease
Table 1
The characteristics of the study population.
| | Variable | All () | Positive () | Negative () | value |
| | Gender, (%) | | | | 0.244 | | Male | 75 (72.8%) | 47 (77.1%) | 28 (66.7%) | | | Female | 28 (27.2%) | 14 (22.9%) | 14 (33.3%) | | | Age at diagnosis (year) | | | | 0.467 | | A1 (≤16) | 9 (8.7%) | 5 (8.2%) | 4 (9.5%) | — | | A2 (17-40) | 75 (72.9%) | 47 (77.0%) | 28 (66.7%) | — | | A3 (>40) | 19 (18.4%) | 9 (14.8%) | 10 (23.8%) | — | | Location, (%) | | | | 0.916 | | L1 (ileal) | 35 (34.0%) | 20 (32.8%) | 15 (35.7%) | — | | L2 (colonic) | 7 (6.8%) | 5 (8.2%) | 2 (4.8%) | — | | L3 (ileocolonic) | 39 (37.9%) | 23 (37.7%) | 16 (38.1%) | — | | L4 (upper gastrointestinal) | 22 (21.3%) | 13 (21.3%) | 9 (21.4%) | — | | Behavior, (%) | | | | 0.920 | | B1 (nonstricturing/penetrating) | 4 (3.9%) | 2 (3.2%) | 2 (4.8%) | — | | B2 (stricturing) | 70 (68.0%) | 42 (68.9%) | 28 (66.7%) | — | | B3 (penetrating) | 29 (28.1%) | 17 (27.9%) | 12 (28.5%) | — | | Duration of disease (years) | | | | 0.233 | | <5 | 44 (42.7%) | 29 (47.5%) | 15 (35.7%) | — | | ≥5 | 59 (57.3%) | 32 (52.5%) | 27 (64.3%) | — | | Smoker, (%) | 24 (23.3%) | 18 (29.5%) | 6 (14.3%) | 0.073 | | Place of living, (%) | | | | 0.971 | | Rural | 37 (35.9%) | 22 (36.1%) | 15 (35.7%) | — | | Urban | 66 (64.1%) | 39 (63.9%) | 27 (64.3%) | | | Marital status, (%) | | | | 0.09 | | Single | 30 (29.1%) | 21 (34.4%) | 9 (21.4%) | | | Married | 72 (69.9) | 39 (63.9%) | 33 (78.6%) | | | Divorced | 1 (1.0%) | 1 (1.7%) | 0 (0%) | | | Education level, (%) | | | | 0.151 | | Middle school or below | 55 (53.4%) | 29 (47.5%) | 26 (61.9%) | — | | College degree or above | 48 (46.6%) | 32 (52.5%) | 16 (38.1%) | — | | Financial burden, (%) | | | | 0.046 | | Having no debt | 49 (47.6%) | 34 (55.7%) | 15 (35.7%) | — | | Being in debt | 54 (52.4%) | 27 (44.3%) | 27 (64.3%) | — | | Prior bowel resection, (%) | 34 (33.0%) | 19 (31.1%) | 15 (35.7%) | 0.628 | | Medical therapy at time of surgery, (%) | | | | 0.658 | | Conventional therapy | 62 (60.2%) | 36 (59.0%) | 26 (61.9%) | — | | Antitumor necrosis factor | 24 (23.3%) | 14 (23.0%) | 10 (23.8%) | — | | Other or no medicine | 17 (16.5%) | 11 (18.0%) | 6 (14.3%) | — |
|
|
